With bilaterally small testicular volume, a normal follicle‑stimulating hormone level, and normal sperm concentrations on two semen analyses, should I be concerned about my testicle size and risk of developing azoospermia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Your Testicular Size and Fertility Status

With bilateral 10ml testicular volumes, an FSH of 9.7 IU/L (within normal range), and two normal semen analyses showing 56 and 45 million/ml sperm concentrations, you should not be concerned about becoming azoospermic—your current fertility parameters are reassuring and indicate active spermatogenesis despite reduced testicular reserve. 1, 2

Understanding Your Current Status

Your situation reflects reduced testicular reserve with maintained spermatogenesis, not impending testicular failure:

  • Testicular volume of 10ml bilaterally falls just below the 12ml threshold that defines testicular atrophy, placing you in a borderline-small category that warrants monitoring but does not predict azoospermia. 1, 3

  • Your FSH of 9.7 IU/L is within the normal laboratory range (1-12.5 IU/L) and does not meet the >7.6 IU/L threshold strongly associated with non-obstructive azoospermia when accompanied by testicular atrophy and absent sperm. 1

  • Your sperm concentrations of 56 and 45 million/ml far exceed the WHO reference limit of 16 million/ml, confirming normal sperm production despite smaller testicular volumes. 2

Why You Are Not Likely to Become Azoospermic

The combination of your parameters indicates oligospermia risk, not azoospermia:

  • Men with testicular volumes of 10-12ml and FSH levels in your range typically have oligospermia rather than azoospermia, with FSH >7.6 IU/L indicating impaired but not absent spermatogenesis. 1

  • Up to 30% of men with azoospermia, markedly elevated FSH (>3 times normal), and testicular atrophy still have retrievable sperm on testicular biopsy, demonstrating that even severe cases maintain focal spermatogenesis. 4

  • Your documented sperm production on two separate analyses confirms active spermatogenesis, making progression to complete azoospermia unlikely in the absence of additional insults. 1, 2

Critical Protective Actions

To prevent any decline in your fertility parameters, avoid these common pitfalls:

  • Never use exogenous testosterone or anabolic steroids, as these completely suppress spermatogenesis through negative feedback on FSH and LH, causing azoospermia that can take months to years to recover. 1, 2

  • Avoid gonadotoxic exposures including chemotherapy, radiation, excessive heat to the testes, smoking, and occupational toxins (lead, cadmium, oil/gas extraction). 1

  • Maintain optimal metabolic health with BMI <25, as obesity and metabolic syndrome impair male fertility through disruption of the hypothalamic-pituitary-gonadal axis. 1

Recommended Monitoring Protocol

Given your reduced testicular reserve, implement this surveillance strategy:

  • Repeat semen analysis every 6-12 months to detect early decline in sperm parameters, as single analyses can be misleading due to natural variability. 2

  • Obtain complete hormonal panel (FSH, LH, total testosterone, SHBG to calculate free testosterone) if sperm concentration drops below 20 million/ml on follow-up testing. 1, 2

  • Consider sperm cryopreservation (banking 2-3 separate ejaculates) if follow-up semen analysis shows declining trend, especially if approaching 20 million/ml or dropping below 5 million/ml. 1, 2

  • Perform physical examination checking for varicocele presence, testicular consistency, and epididymal abnormalities, as varicocele repair can improve semen parameters and halt testicular atrophy progression. 1

When to Seek Further Evaluation

Urgent urology referral is indicated if:

  • Sperm concentration drops below 5 million/ml, at which point karyotype analysis and Y-chromosome microdeletion testing (AZFa, AZFb, AZFc regions) become mandatory. 1, 2

  • Rapid testicular atrophy occurs (>2ml or 20% size discrepancy develops between testes). 3

  • Palpable testicular mass develops, given the 3.6-7.4 times higher risk of germ cell tumors in men with small testicular volumes. 3

Fertility Preservation Timing

If you are planning future fertility, consider these time-sensitive factors:

  • Your current sperm parameters support excellent natural conception rates, with total motile sperm count far exceeding the 10 million threshold associated with good natural conception probability. 2

  • Female partner age is the most critical factor determining conception success—couples with female partner under 30 have >90% chance of achieving pregnancy within 2-3 years of trying. 1

  • Sperm cryopreservation is not currently indicated given your adequate sperm concentration, but should be reconsidered if parameters decline on follow-up testing. 2

Important Caveats

Your FSH level, while within normal laboratory range, warrants attention:

  • Research suggests that FSH levels >4.5 IU/L are associated with five- to thirteen-fold higher risk of abnormal sperm concentration and morphology compared to FSH <2.8 IU/L, indicating that "normal" laboratory ranges may not reflect optimal fertility. 5

  • However, your documented normal sperm production on two analyses confirms that your FSH level is not preventing spermatogenesis, making this a theoretical concern rather than a practical problem. 2

  • FSH levels alone cannot definitively predict fertility status—up to 50% of men with non-obstructive azoospermia and elevated FSH still have retrievable sperm, demonstrating the variable correlation between hormonal levels and actual sperm production. 1

References

Guideline

Non-Obstructive Azoospermia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Fertility Assessment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Testicular Size and Volume Measurement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

With a normal FSH level and low sperm count, is testicular atrophy likely and is azoospermia unlikely in a male of reproductive age?
Should I be concerned about my fertility with a testicular size of 10ml, sperm concentration of 100 million/ml, and a Follicle-Stimulating Hormone (FSH) level of 10.2?
What are the implications and management options for a male of reproductive age with bilateral testicular atrophy, normal sperm count and testosterone levels, but elevated Follicle-Stimulating Hormone (FSH) levels?
Does a decrease in Follicle-Stimulating Hormone (FSH) levels from 11 to 9.8 in a male patient indicate testicular atrophy?
Is a patient with normal testosterone levels, good sperm count (56 million/ml), normal luteinizing hormone (LH) level (7), and slightly elevated follicle-stimulating hormone (FSH) level (9.9) likely to have testicular atrophy?
Is a fixed‑dose clindamycin 1 %/benzoyl peroxide 5 % topical gel available for a patient with cystic acne and a possible draining sinus tract awaiting dermatology referral?
How should a recurrent Bartholin gland cyst on the labia be evaluated and managed?
What is the recommended metronidazole (Flagyl) dosage for treating Trichomonas vaginalis infection in adults and children?
What initial work‑up is indicated for a woman with a two‑year history of infertility and anovulation?
What is the volume in milliliters of one unit of packed red blood cells?
What are the recommended desmopressin (DDAVP) doses for adult central diabetes insipidus, children with nocturnal enuresis, and mild hemophilia A or von Willebrand disease, and how should dosing be adjusted in renal impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.